Long-term outcomes of neoadjuvant chemotherapy (NAC) before bladder-sparing chemoradiotherapy (CRT) for patients with nonmetastatic muscle-invasive bladder cancer (MIBC). This is an ASCO Meeting ...
Thus, Rho family proteins have begun to rival, if not overshadow, interest in their more celebrated cousins, the Ras oncogene proteins. The fascination in Rho family proteins is fueled primarily ...
Problems arise, however, when mutations convert the proto-oncogene to an oncogene, rendering Ras permanently active regardless of the signals the cell receives. How do tumor suppressors differ?
18d
GlobalData on MSNServier and Black Diamond sign deal for solid tumours therapyThe study includes adults with advanced or metastatic cancers that exhibit mutations in the B-Raf proto-oncogene, serine/threonine-protein kinase (BRAF), CRAF or neuroblastoma RAS viral oncogene ...
The study includes adults with advanced or metastatic cancers that exhibit mutations in the B-Raf proto-oncogene, serine/threonine-protein kinase (BRAF), CRAF or neuroblastoma RAS viral oncogene ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results